US FDA’s Narrow Path For Imports: Beware The 'SIP'-pery Slope
Executive Summary
Newly proposed pathway to allow states to pursue wholesale importation of drugs from Canada is extremely narrow and restrictive, at least in draft form. It is still a terrible precedent for industry – one that can be easily expanded if it takes effect.